VML-0501
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VML-0501, covering 2020-06-12 to 2020-06-12. Get the full timeline:
Most recent: Clinical Trial Update: Study to Determine Intraperitoneal,Tissue, Serum Concentrations of VML-0501 Following Five Days of Daily Vaginal Single Dose of VML-0501 (100 mg Danazol), in Comparison to Oral Danazol Capsules Daily 600 mg), in Women With Signs and Symptoms of Endometriosis Undergoing Laparoscopy [Phase 2]